MINIMALLY INVASIVE SURGERY MARKET INTRODUCTION

In comparison to traditional open surgery, minimally invasive surgery (MIS) refers to surgical techniques that minimize the size of incisions required, thereby minimizing the risk of infection, related discomfort, and the time it takes for wounds to heal. This method uses specialized tools and cutting-edge technology to gain access inside organs through small portals, often less than an inch long.

MARKET OVERVIEW

The minimally invasive surgery market is valued at approximately USD 81.65 billion in 2024 and is projected to reach USD 421.80 billion by 2035 exhibiting a compound annual growth rate (CAGR) of 16.1% during the forecast period of 2025-2035. Their primary advantages include less scarring, quicker recovery, shorter hospital stays, less pain, and a lower risk of complications such as infection and blood loss.

GROWTH DRIVERS

The increasing patient preference for operations that provide a shorter recovery time, less scarring, and fewer postoperative problems is one of the main factors driving market growth. MIS techniques use smaller incisions, compared to traditional open surgeries that have large incisions, which reduces blood loss, infection risk, and the overall recovery time. According to the IntechOpen, MIS has the potential to lower long-term costs by reducing hospital stays, quick recovery times, and fewer complications. These benefits enable a quicker return to regular activities, lower overall healthcare expenses, and increase patient satisfaction.

The demand for minimally invasive solutions is fueled by the rising prevalence of chronic diseases, such as obesity, diabetes, cancer, and cardiovascular disorders, that require surgical interventions. These disorders are increasingly prevalent in the elderly, and as the world's population ages, surgical procedures like MIS, which shorten recovery periods and reduces risks, are increasingly becoming necessary. For instance, the World Health Organization (WHO) estimates that the number of individuals worldwide who are 60 years of age or older is expected to rise from 1.1 billion in 2023 to 1.4 billion by 2030, which is projected to increase demand for MIS. Furthermore, according to the American Cancer Society, there is going to be 9.7 million cancer-related deaths and 20 million new instances of cancer worldwide in 2025, which is going to raise demand for MIS.

MARKET SEGMENTATION:

By Product -

·         Surgical Devices

o   Handheld Instruments

·         Dilators

·         Probes

·         Tubular Retractors

·         Laser Fiber Devices

·         Suturing Instruments

·         Others

o   Inflation Systems

·         Balloon Inflation Systems

·         Balloon Catheters

·         Others

o   Laparoscopy Devices

·         Laparoscopes

·         Graspers & Dissectors

·         Trocars & Cannulas

·         Others

o   Guiding Devices

·         Guidewires

·         Guiding Catheters

·         Others

o   Others

·         Endoscopy Devices

o   Rigid Endoscopes

o   Flexible Endoscopes

o   Others

·         Electrosurgical Devices

o   Electrosurgical Generators & Accessories

o   Electrocautery Devices

o   Others

·         Imaging & Visualization Systems

o   CT Scanners

o   MRI Systems

o   Ultrasound Systems

o   Visualization Systems

o   X-Ray Systems

o   Others

·         Medical Robotics

o   Robotic Systems

o   Robotic Software & Services

·         Others

·         By Application –

o   Gastrointestinal & Abdominal Surgery

o   Gynecological Surgery

o   Urological Surgery

o   Cosmetic Surgery

o   Vascular Surgery

o   Cardiothoracic Surgery

o   Neurological Surgery

o   Ear, Nose and Throat (ENT) & Respiratory Surgery

o   Orthopedic & Spinal Surgery

o   Oncological Surgery

o   Dental Surgery

o   Others

·         By End User –

o   Hospitals

o   Clinics

o   Emergency & Trauma Centers

o   Ambulatory Surgery Centers (ASCs)

o   Others

·         By Region -

o   North America

o   Europe

o   Asia Pacific

o   Latin America

o   Middle East & Africa

Minimally Invasive Surgery Market By Product Segment Review:

In 2025, surgical devices segment is anticipated to hold the largest share of the market. The use of these devices is vital for reaching the surgical site, handling tissues, and performing resections or repairs through small ports. The demand for advanced surgical devices is fueled by the constant advancement of ergonomic designs, enhanced material science, and the integration of smart features.

Minimally Invasive Surgery Market By Application Segment Review:

The gastrointestinal & abdominal surgery segment is anticipated to hold a significant share of the MIS market due to the high prevalence of gastrointestinal disorders worldwide and the growing preference for laparoscopic and robotic-assisted procedures for conditions like appendicitis, cholecystectomy, hernia repair, and colorectal surgeries.

Minimally Invasive Surgery Market By End User Segment Review:

In 2025, hospitals’ segment is anticipated to hold the largest share of the market due to capability to handle high-acuity cases, the availability of specialized equipment, and their ability to manage complications.

Minimally Invasive Surgery Market By Region Segment Review:

The minimally invasive surgery market exhibits significant regional variations, with North America leading the market in 2024 due to its sophisticated healthcare infrastructure, high adoption of advanced surgical technologies, favorable government reimbursement policies, and the high prevalence of chronic diseases.

Minimally Invasive Surgery Market Regional Synopsis:

The market in North America is growing due to the increasing patient preference for minimally invasive procedures, technological advancements and innovation, rising incidence of chronic diseases, its well-established healthcare infrastructure and favorable reimbursement policies, and growing number of ambulatory surgical centers.

Europe is another crucial market, driven by the continuous technological advancements, increasing patient and healthcare provider awareness of its benefits, and a rising prevalence of chronic diseases necessitating surgical interventions.

The market in Asia Pacific is expected to expand rapidly due to its rapidly aging population, increasing prevalence of chronic diseases, rising adoption of advanced surgical technologies, and improving healthcare infrastructure.

The Latin American minimally invasive surgery market is experiencing steady progress due to increasing prevalence of chronic diseases, rising healthcare expenditure, and growing patient and government preference for less invasive procedures.

The growth of the minimally invasive surgery market in the Middle East and Africa is primarily driven by increasing demand for less invasive procedures, technological advancements, and supportive healthcare initiatives.

Key Challenges:

The high cost associated with MIS technologies, especially robotic surgical systems, is one of the main factors hindering the growth of this market. Healthcare facilities, especially smaller hospitals and those in resource-constrained environments, face a significant financial burden due to these high upfront and continuing costs. This cost barrier also prevents advanced MIS technologies from being adopted in rural or underdeveloped locations and restricts their availability to large, well-funded medical facilities. In certain regions, the high cost of equipment also leads to treatment avoidance or delays.

Competitive Landscape:

The global MIS market is highly competitive, characterized by a several established players, each striving to enhance their market presence through various strategies such as product innovation, strategic partnerships, mergers, acquisitions, geographic expansion, investing in training programs, navigating the complex and evolving regulatory landscapes, and addressing the high cost of mis systems through value-based pricing models and technological innovations that improve affordability.

In the minimally invasive surgery market, companies are increasingly prioritizing product innovation and technological advancements. Businesses are making significant investment in research and development to develop cutting-edge robotically assisted surgical systems, AI-powered tools, and high-definition imaging technology to improve accuracy, surgical proficiency, and visualization.

Key Players:

·         Medtronic

·         Johnson & Johnson

·         Stryker

·         Abbott

·         Boston Scientific Corporation 

·         Zimmer Biomet

·         B. Braun SE

·         Globus Medical

·         Integra LifeSciences Corporation

·         Siemens Healthineers International AG

·         Fujifilm Group

·         Becton, Dickinson and Company (BD)

·         Cook

·         Intuitive Surgical Operations, Inc.

·         Other Key & Niche Players